Industry Resources

Staying current with new guidelines, regulations and best practice are vital to professionals in the pharmaceutical industry. The PSG Industry Resource Page consists of selected resources from the Canadian Government, Health Canada, and the FDA. Its aim is to provide easy access to important updates in order to support our members. These resources include updates regarding the COVID-19 pandemic and its impact on certain guidelines.  Please click on the links below to learn more.




  1. Drug Establishment Licence
  2. Letter to importers of drugs licensed under Division 1A of the Food and Drug Regulations
  3. Revised Drug Establishment Licences (DEL) Guides and Form
  4. Exceptional Importation Proposal Form
  5. GUI-0012 - Annex 4 to the Good Manufacturing Guide - Veterinary Drugs
  6. GUI-0012 Comment Form
  7. HC Form - Exceptional Release of Disinfectant & Sanitizing Products
  8. Proposal for Including Non-Compliant Drug Under the Interim Order on the list of Drugs for Exceptional Importation and Sale
  9. DEL Bulletin 89 - Coming into Force of Regulatory Amendments
  10. GUI-0117_Importing and Exporting Health Products for Commercial Use
  11. GUI-0001 - GMP Guide for Drug Products - *Date Issued: July 2020
  12. GUI-0069 - Guidelines for Environmental Control of Drugs during Storage and Transportation - *Date Issued: August 2020
  13. FAQ-IO Drug Authorization-final-2020-09-15
  14. Guidance for Interim Order Respecting the Prevention and Alleviation
    of Shortages of Drugs in Relation to COVID-19

  1. Coronavirus Disease 2019 (COVID-19)
  2. Emergency Use Authorizations
  3. Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency
  4. Coronavirus Treatment Acceleration Program (CTAP)


  1. NRC COVID-19 programs